Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230371 | 12723037 | 1 | I | 2016 | 20160801 | 20160908 | 20160908 | PER | US-CELGENEUS-USA-2016080375 | CELGENE | 0.00 | M | Y | 0.00000 | 20160908 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230371 | 12723037 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0028AH | 20785 | 200 | MG | CAPSULES | QD | ||||
| 127230371 | 12723037 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 200-100 MG | U | U | B0028AH | 20785 | CAPSULES | QD | |||||
| 127230371 | 12723037 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 100-50 MG | U | U | B0028AH | 20785 | CAPSULES | QD | |||||
| 127230371 | 12723037 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0028AH | 20785 | 50 | MG | CAPSULES | QD | ||||
| 127230371 | 12723037 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 6 | C | Dexmethasone | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 8 | C | PREVACID | LANSOPRAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 9 | C | Oxycodone | OXYCODONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 10 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127230371 | 12723037 | 11 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127230371 | 12723037 | 1 | Plasma cell myeloma |
| 127230371 | 12723037 | 5 | Product used for unknown indication |
| 127230371 | 12723037 | 6 | Product used for unknown indication |
| 127230371 | 12723037 | 7 | Product used for unknown indication |
| 127230371 | 12723037 | 8 | Product used for unknown indication |
| 127230371 | 12723037 | 9 | Product used for unknown indication |
| 127230371 | 12723037 | 10 | Product used for unknown indication |
| 127230371 | 12723037 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127230371 | 12723037 | Hypoaesthesia | |
| 127230371 | 12723037 | Mouth ulceration | |
| 127230371 | 12723037 | Oropharyngeal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127230371 | 12723037 | 1 | 200610 | 0 | ||
| 127230371 | 12723037 | 2 | 20091027 | 0 | ||
| 127230371 | 12723037 | 3 | 201306 | 0 | ||
| 127230371 | 12723037 | 4 | 201405 | 0 |